They trust us
Production and distribution of active pharmaceutical ingredients (APIs) for healthcare professionals.
A
CSR Analysis score
The organization is among the top 5% of organizations with the most committed CSR positioning, among comparable organizations.
+160,000
Total organizations analyzedAnalysis by axis
Access the detailed report with all sector benchmarks, in-depth competitive analysis and actionable recommendations.
Methodology: Score calculated according to 6 CSR themes (Carbon, Biodiversity, Circular Economy, Sustainable Investments, Governance, Social Impact)
Sources: Public data, CSR reports, documented initiatives, official databases
Last update: March 2026
This analysis is not yet available in English. Please see the French version.
Leading organizations
CordenPharma
B
Development and manufacturing of active pharmaceutical ingredients (APIs), drug products, and lipid excipients for the pharmaceutical industry.
Minakem
B
Development and production of active pharmaceutical ingredients (APIs) and highly active pharmaceutical ingredients (HAPIs) for cancer treatments.
Octapharma France
B
Development and distribution of therapeutic pharmaceutical products for healthcare professionals and patients.
Initiatives identified among leaders
Audits réguliers pour évaluer et améliorer la sécurité et l'environnement
“Minakem réalise régulièrement des audits en matièr...” - MinakemCertifications ISO pour gestion environnementale, santé-sécurité et énergie
“Corden Pharma Fribourg AG (site Ettingen) a obtenu...” - CordenPharmaRéduction des risques et amélioration des conditions de travail en production.
“Octapharma France a mis en place des actions pour ...” - Octapharma France57% of similar organizations communicate on CSR issues
+583 initiatives collected from 49 similar organizations
Is your score incomplete? Update your CSR information and improve your positioning.
Claim this page
Updated data
Personalized recommendations
Access complete data, competitive analyses and actionable recommendations for your clients.
Comprehensive sector benchmarks
Competitive data
Ready-to-use reports